Lee Greenberger

Lee Greenberger has a strong background in scientific research and leadership roles within the pharmaceutical and medical industry. Lee is currently serving as the Chief Scientific Officer at The Leukemia & Lymphoma Society, a position they have held since 2013. Prior to this, they held the position of Global Therapeutic Head of Oncology and Immunology at Bristol-Myers Squibb from 2012 to 2013. From 2006 to 2012, they served as the Vice President of Research at Enzon Pharmaceuticals, Inc. Before that, they worked as a Senior Research Fellow at Johnson & Johnson from 2005 to 2006. From 1991 to 2005, they held the role of Senior Director at Wyeth Research. Lee began their career as a Research Associate at Albert Einstein Medical Center from 1986 to 1990 after working as a Post-doctoral Associate at Columbia University from 1984 to 1986.

Lee Greenberger completed their B.A in Interdepartmental Neurosciences at the University of Rochester from 1973 to 1977. They then pursued a Ph.D. in Anatomy and Cell Biology at Emory University from 1979 to 1984.